ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Florida Surgeon General calls for halt to COVID-19 vaccine usage after FDA said he spread misinformation

Florida Surgeon General Dr. Joseph Ladapo is calling for a halt to the use of mRNA COVID-19 vaccines made by Pfizer and Moderna, citing various health risks.

Florida State Surgeon General Dr. Joseph Ladapo is calling on healthcare providers to halt the use of COVID-19 mRNA vaccines, citing purported health risks labeled "misinformation" by federal officials. 

In a bulletin issued Wednesday, Ladapo claimed the U.S. Food and Drug Administration (FDA) has not shown evidence that coronavirus vaccines manufactured by Pfizer and Moderna have been assessed for "nucleic acid contaminants" that could cause cancer. Disputing claims by the FDA that such risk is "implausible," Ladapo called for an immediate stoppage to the use of the approved mRNA COVID-19 vaccines.

"I am calling for a halt to the use of mRNA COVID-19 vaccines," the Florida surgeon general said in a statement. 

"The U.S. Food and Drug Administration and the Centers for Disease Control and Prevention have always played it fast and loose with COVID-19 vaccine safety, but their failure to test for DNA integration with the human genome — as their own guidelines dictate — when the vaccines are known to be contaminated with foreign DNA is intolerable," he asserted. 

NEW COVID VACCINE PUSH IS ‘ANTI-HUMAN,' SAYS FLORIDA SURGEON GENERAL: ‘MAJOR SAFETY CONCERN’

A top FDA official last month pushed back against Ladapo and what the FDA called "the proliferation of misinformation" on vaccine safety.

Ladapo raised concerns about the agency's approval of mRNA COVID-19 vaccines in a Dec. 6 letter to FDA Commissioner Dr. Robert M. Califf and CDC Director Dr. Mandy Cohen. His letter cited a pre-print study that, according to the surgeon general, showed there are "billions of DNA fragments per dose of the Pfizer and Moderna COVID-19 mRNA vaccines." 

Pointing to FDA guidance on vaccines that "use novel methods of delivery regarding DNA integration," Ladapo questioned whether the Pfizer and Moderna mRNA vaccines had been assessed to meet FDA's standards, noting a potential risk of cancer.

In a written response, Dr. Peter Marks, director of the Center for Biologics Evaluation and Research, wrote that it is "implausible" that residual small DNA fragments could find their way into the nucleus of human cells and then alter DNA to cause cancer.

NEW COVID VARIANT JN.1 NOW COMPRISES UP TO 30% OF US CASES: CDC

"We would like to make clear that based on a thorough assessment of the entire manufacturing process, FDA is confident in the quality, safety, and effectiveness of the COVID-19 vaccines," Marks wrote in a Dec. 14 letter. "Additionally, with over a billion doses of the mRNA vaccines administered, no safety concerns related to residual DNA have been identified." 

Marks went on to say that the chief challenge regulators face "is the ongoing proliferation of misinformation and disinformation about these vaccines which results in vaccine hesitancy that lowers vaccine uptake."

However, Ladapo contends FDA did not answer his questions. 

"The FDA’s response does not provide data or evidence that the DNA integration assessments they recommended themselves have been performed," the surgeon general said in a statement. "Instead, they pointed to genotoxicity studies — which are inadequate assessments for DNA integration risk. In addition, they obfuscated the difference between the SV40 promoter/enhancer and SV40 proteins, two elements that are distinct." 

COLD, FLU, COVID-19 AND RSV: HOW TO IDENTIFY THE DIFFERING SYMPTOMS AND STAY SAFE

"DNA integration poses a unique and elevated risk to human health and to the integrity of the human genome, including the risk that DNA integrated into sperm or egg gametes could be passed onto offspring of mRNA COVID-19 vaccine recipients," Ladapo continued. "If the risks of DNA integration have not been assessed for mRNA COVID-19 vaccines, these vaccines are not appropriate for use in human beings." 

The FDA did not immediately respond to a request for comment. 

In a statement, Pfizer reiterated that regulatory agencies across the globe have authorized the use of its mRNA vaccine and found it safe and effective. 

"These authorizations are based on robust and independent evaluation of the scientific data on quality, safety and efficacy, including our landmark phase 3 clinical trial. Data from real world studies complement the clinical trial data and provide additional evidence that the vaccine provides effective protection against severe disease," Pfizer told Fox News Digital. 

"Over the course of this deadly pandemic, mRNA vaccines have saved hundreds of thousands of lives, tens of billions of dollars in health care costs, and enabled people worldwide to go about their lives more freely. We have delivered more than 4 billion vaccines to 181 countries and territories in every region of the world."

Moderna did not immediately respond to a request for comment. 

Ladapo has previously clashed with the FDA and CDC. In March, the health agencies accused him of misleading the public on COVID-19 vaccine side effects by highlighting rare adverse events and downplaying the benefits of vaccination.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.